With regard to courses of action, it is important that the industry be able to mobilize on the basis of clear objectives. We therefore need to establish strategic planning and to determine where we want to go. We have to mobilize researchers to make the breakthroughs we need.
The industry is mobilized, but we have to focus on the type of research findings because research findings are not transferred in the same way. If you develop a new vaccine or animal feed product, intellectual property is involved and royalties are paid. A contract is signed and a licence is granted. This type of transfer can be done quickly, if everything in the area of intellectual property is clear and the approval mechanisms and regulations facilitate matters.
There are other types of innovations that do not immediately generate marketable benefits for a seller of inputs or products. The strategies in that instance are different.
Consequently, from the moment we agree on a research orientation or on the findings we want to reach, we must immediately establish our transfer strategies to ensure we recover them to the maximum degree.
There's no single answer for that. However, partners have to be mobilized. We need people around the table who will be able to generate that knowledge—the scientists—and also people who know how to transfer it quickly and who know the tools we need.
That can only be done if information is shared within the context of a structure, if the communication among the various partners is good and if people are seated around the same table.
That, I believe, is what we're trying to do with the scientific cluster approach. It facilitates research.